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On a daily basis, endogenous and exogenous
agents induce cellular DNA damage. If not
repaired, the damage can interfere with
important cellular functions and can cause
serious health problems such as cancer.
Therefore, a variety of DNA repair processes
such as the base excision repair (BER),
nucleotide excision repair (NER), and mis-
match and double-strand break repairs
have evolved to perform the critical repair
functions (Dybdahl et al. 1999; Friedberg
2003). The BER pathway is involved in the
repair of DNA damage caused by a variety
of internal and external factors including
ionizing radiation, alkylating agents, and
oxidation. XRCC1 and Ape1 enzymes play
important roles in the BER pathway. The
Ape1 protein incises the phosphodiester
backbone of DNA immediately 5´ to the
baseless lesion, leaving a strand break with
a normal 3´-hydroxyl group and a noncon-
ventional 5´-abasic terminus (Wilson and
Barsky 2001). XRCC1 acts as a scaffold for
other DNA repair proteins such as DNA
polymerase β and DNA ligase II (reviewed
by Caldecott 2003). The XRCC3 protein
functions in the homologous DNA double-
strand break repair pathway and directly
interacts with and stabilizes Rad51 (Bishop
et al. 1998). NER is the major pathway in
humans for the removal of cyclopyrimidine
dimers and 6–4 photoproducts produced
by ultraviolet (UV) light and a wide variety
of bulky lesions formed by chemical agents
(Friedberg et al. 1995). XPD proteins are
involved in the NER pathway. They stabi-
lize the transcription factor complex
TFIIH and have 5→3´ DNA helicase
activity (Lehmann 2001).
Mutations that affect the function of
DNA repair enzymes are rare in the human
population because they can cause serious
health consequences. However, with the
advent of the human genome program,
variations in DNA sequences of repair
genes were discovered recently (Shen et al.
1998). The surprise was that the frequen-
cies of the variant gene alleles, based on
single nucleotide polymorphisms, reached
the polymorphism level in the population.
In addition some of the polymorphisms
may not be innocuous variations because
the alterations can be predicted to cause the
substitution of amino acids in the repair
enzymes, presumably altering their repair
functions (Mohrenweiser and Jones 1998;
Shen et al. 1998). However, the functions
of the variant genotypes have not yet been
well characterized.
The discovery of DNA repair gene
polymorphism has stimulated tremendous
interest in research to determine if the vari-
ant genotypes are associated with cancer.
Significant associations with lung cancer,
head and neck cancer, and bladder cancer
have been reported (Butkiewicz et al. 2001;
Spitz et al. 2001; Stern et al. 2002; Sturgis
et al. 2002; Tomescu et al. 2001; Zhou et
al. 2003). However, a high number of the
observations were not consistent with each
other (reviewed by Benhamou and Sarasin
2002; Goode et al. 2002; Hu et al. 2002).
In addition unexpected observations were
reported. For example, inheritance of XPA
variant alleles was associated with reduced
risk for lung cancer (Wu et al. 2003). In
association with the variant genotypes for
XRCC1 and ERCC3, the risk for lung can-
cer decreased as the pack-years of smoking
increased (Zhou et al. 2003). There have
been many proposed explanations to
address the discrepancies. The consistent
recommendation is that the functionalcon-
sequences of the polymorphisms need to
be characterized. 
We have conducted an investigation to
elucidate DNA repair function of certain
variant genotypes using our cytogenetic
challenge assays (Au 1993; Au et al. 1991;
El Zein et al. 1995). The challenge assays
have been validated to indicate abnormal
DNA repair responses to X rays and to
UV light on the basis of studies using the
host cell reactivation assay and patients
with skin cancer susceptibility (El Zein
et al. 1995; Hallberg et al. 1997).
Specifically, we have selected two groups
of polymorphic DNA repair genes prefer-
entially involved with BER and NER
activities that correspond to the repair of
X rays and UV light–induced DNA
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A major barrier to understanding the role of polymorphic DNA repair genes for environmental
cancer is that the functions of variant genotypes are largely unknown. Using our cytogenetic chal-
lenge assays, we conducted an investigation to address the deﬁciency. Using X-rays or ultraviolet
(UV) light, we irradiated blood lymphocytes from 80 nonsmoking donors to challenge the cells to
repair the induced DNA damage, and we analyzed expression of chromosome aberrations (CA)
speciﬁc to the inducing agents. We have genotyped polymorphic DNA repair genes preferentially
involved with base excision repair (BER) and nucleotide excision repair (NER) activities (XRCC1,
XRCC3, APE1, XPD) corresponding to the repair of X-ray– and UV light–induced DNA damage,
respectively. We expected that defects in specific DNA repair pathways due to polymorphisms
would cause corresponding increases of speciﬁc CA. From our data, XRCC1 399Gln and XRCC3
241Met were associated with significant increases in chromosome deletions compared with the
corresponding homozygous wild types (18.27 ± 1.1 vs 14.79 ± 1.2 and 18.22 ± 0.99 vs 14.20 ±
1.39, respectively); XPD 312Asn and XPD 751Gln were associated with signiﬁcant increases in
chromatid breaks compared with wild types (16.09 ± 1.36 vs 11.41 ± 0.98 and 16.87 ± 1.27 vs
10.54 ± 0.87, respectively), p < 0.05. The data indicate that XRCC1 399Gln and XRCC3 241Met
are signiﬁcantly defective in BER, and the XPD 312Asn and XPD 751Gln are signiﬁcantly defec-
tive in NER. In addition, the variant genotypes interact signiﬁcantly, with limited overlap of the
two different repair pathways. Key words: challenge assay, chromosome aberrations, DNA dam-
age, DNA repair, DNA repair gene polymorphisms, genetic susceptibility. Environ Health
Perspect 111:1843–1850 (2003). doi:10.1289/txg.6632 available via http://dx.doi.org/ [Online
6 October 2003]damage, respectively. The relationship
between variant genotypes and the expres-
sion of X rays and UV light–induced
chromosome aberrations (CA) in normal
human lymphocytes was investigated. Our
assumption is that defects in specific
DNA repair pathways would lead to a cor-
responding increase in specific CA. The
data indicate that XRCC1 399Gln and
XRCC3 241Met are associated with
defects in BER, and XPD 312Asn and
XPD 751Gln with NER. 
Materials and Methods
Recruitment of Donors
In this study we recruited volunteers who
were healthy and had a presumably stable
lifestyle. Therefore, we advertised for
healthy males and females who were in
the middle age group (35–40 years of
age), regardless of ethnicity. Potential vol-
unteers were informed about the objec-
tives of the study, the need to donate a
blood sample, and the risk and benefit
from participation in the study. Study
participants filled out a questionnaire for
lifestyle information and medical history
and signed consent forms, according to
the approved protocol from the University
Institutional Review Board. Exclusion cri-
teria were smoking of cigarettes, cigars,
and pipes; previous exposure to radiation
or hazardous chemicals; on medication;
and history of cancer or from cancer fami-
lies. Each qualified volunteer was asked to
donate a single blood sample.
Laboratory Reagents and Cell
Cultures
Standard laboratory culture reagents were
purchased from Gibco Laboratory (Grand
Island, NY) and from Murex Biotech
(Dartford, UK). The primers for genotyp-
ing, DNA Taq polymerase, and restriction
enzymes were purchased from Sigma-
Aldrich (St. Louis, MO).
Blood specimens were collected into
Vacutainer tubes (Sigma-Aldrich) contain-
ing sodium heparin as an anticoagulant.
The specimens were labeled with a prede-
termined code and transported to the labo-
ratory as soon as possible after collection.
Blood cultures were set up according to the
standard procedures in our laboratory (Au
et al. 1991). The cultures were normally set
up within 2 hr from the time blood samples
were drawn from the donors. The culture
medium was made up of RMPI 1640
medium that was supplemented with
10% heat-inactivated fetal bovine serum,
2% phytohaemagglutinin, 100 U/mL
penicillin, 100 µg/mL streptomycin, and
L-glutamine. Cultures were maintained in a
water-jacketed CO2 incubator set up
at 37.5°C. 
The X-Ray Challenge Assay
The challenge assay used in this study was
developed in our laboratory and discussed
in detail elsewhere (Au 1993; Au et al.
1991). For this assay, blood cultures were
set up by placing 0.5 mL whole blood into
culture tubes that each contained 4.5 mL
culture medium as described above (Au
et al. 1991). A Mark I cesium-137 pneu-
matic irradiator with a dose rate of approxi-
mately 80 cGy/min was used for the
irradiation (J.L. Shephard, Glendale, CA).
The cells were irradiated in the culture
tubes 24 hr after culture initiation and the
irradiation dose was 100 cGy. Fifty hours
after culture initiation, cells were harvested
using the standard Colcemid blocking
procedure (Au et al. 1991). 
UV-Light Challenge Assay
The UV challenge assay was described in
our previous publication (El Zein et al.
1995). Under UV irradiation conditions,
target cells need to be irradiated as a
monolayer and without overlap from the
other cell types. Therefore, lymphocytes
were isolated from whole blood using
Histopaque 1077 (Sigma-Aldrich) and
used to set up the cultures (500,000
cells/mL in 5 mL culture, using the same
culture medium described earlier).
Twenty-four hours after initiation of the
lymphocyte cultures, the culture tubes
were centrifuged to pack cells. The super-
natant medium was removed and saved for
reuse after the irradiation. The packed cells
from each culture were resuspended in
2 mL sterile saline and put into a 100-mL
Petri dish for irradiation. With the small
volume of saline, the cells were therefore
spread out into a thin layer with limited
overlapping of cells. The source of UV
light was a 15-W short-wave tube that pro-
duced a peak of intensity of 1,100 µW/cm2
of 254 nm at 15 cm distance. The irradia-
tion dose was 4 J/m2 for 4 sec. The irradia-
tion was performed in a lamina ﬂow hood
with the lids of the Petri dishes removed.
After the irradiation, cells were resus-
pended in their own growth medium
saved earlier and allowed to grow for an
additional 26 hr before harvesting.
Cell Harvesting 
Before harvest, cells were blocked with
Colcemid (final concentration 0.1 µg/mL)
for 1.5 hr. After removal of the culture
medium, cells were treated with hypotonic
solution (0.075 M KCl) and fixed with
Carnoy’s ﬁxative (methanol and glacial acetic
acid at 3:1 ratio). Cytological preparations
were made, coded, and stained with 10%
Giemsa solution for 15 min. The stained
slides were air dried, and a cover slip was
then put onto each slide. Under the micro-
scope, metaphase cells were located and ana-
lyzed for the presence of CA (Au et al.
1991). Fifty metaphase cells were analyzed
for every exposure condition and the data are
expressed as percentages. One individual did
all analyses using coded slides.
DNA Isolation and Genotyping
Genomic DNA was extracted from isolated
lymphocytes by a standard nonorganic pro-
cedure (Miller et al. 1988). The extracted
DNA was used for characterization of the
following polymorphic DNA repair genes.
These polymorphic genes were chosen
because they reportedly are associated with
several environmental cancers (Butkiewicz
et al. 2001; Misra et al. 2003; Smith et al.
2003; Sturgis et al. 2002; Tomescu et al.
2001; Zhou et al. 2003). Polymerase chain
reaction (PCR), followed by restriction
fragment length polymorphism, was used
for genotyping. All genotype assays were
performed twice, and the repeat analyses
were conducted independent of each other.
Only concordant findings from these
analyses were accepted.
For determination of polymorphism
XRCC1 Arg194Trp, 100 ng genomic DNA
was ampliﬁed in a total volume of 50 µL con-
taining 0.2 µM of the following primer pairs:
forward, 5´-GCCCCGTCCCAGGTA-3´,
reverse, 5´-AGC CCC AAG ACCC TTT-3´,
1× PCR buffer (150 mM Tris-HCl, pH 0.8,
500 mM KCl), 2.5 mM MgCl2, 0.2 mM
each deoxynucleoside triphosphate (dNTP),
and 1 U Taq polymerase. The PCR ampliﬁ-
cation condition consisted of initial denatura-
tion step at 95°C for 2 min, followed by 40
cycles of 94°C for 15 sec, 57°C for 45 sec,
72°C for 45 sec, and ﬁnal extension step at
72°C for 5 min. The PCR products (490 bp)
were digested overnight with the restriction
enzyme PvuII. The restricted products of
XRCC1 codon 194 Arg/Arg, Arg/Trp, and
Trp/Trp genotypes had band sizes of 490,
490/294/196, and 294/196 bp, respectively
(Hu et al. 2001). 
For the XRCC1 Arg399Gln genotyp-
ing, 100 ng genomic DNA was amplified
in a total reaction volume of 50 µL con-
taining 0.2 µM of each of the forward
primer, 5´-CAAGTACAGCCAGGTCC-
TAG-3´, reverse primer, 5´-CCTTCC-
CTCA TCTGGAGTAC-3´, 1× PCR
buffer (150 mM Tris-HCl, pH 0.8, 500
mM KCl), 1.5 mM MgCl2, 0.2 mM each
dNTP, and 1 U Taq polymerase. The PCR
ampliﬁcation condition consisted of initial
denaturation step at 95°C for 2 min, fol-
lowed by 40 cycles of 94°C for 15 sec,
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extension step at 72°C for 5 min. The
248-bp PCR products were digested with
NciI (Promega, Madison, WI); the Arg
allele was cut into 89 and 159 bp frag-
ments (Gln allele not digested) (Matullo
et al. 2001).
Polymorphism in exon 10 of XPD,
which contains G/A, Asp312Asn, was deter-
mined using the method described by Spitz
et al. (2001). The oligonucleotide primers
5´-CTGTTGGTGGGTGCCCGTATCT-
GTTGGTCT-3 (bases 22872–22901 of
XPD) and 5´-TAATATCGGGGCTCAC-
CCTGCAGCACTTCCT (bases 23592–
23616 of XPD) were used. PCR was per-
formed in 50-µL reaction mixtures contain-
ing 1.5 mM MgCl2, 0.2 mM dNTP, 3%
dimethyl sulfoxide, 0.2 µM primers, 100 ng
template DNA, and 1.5 units Taq poly-
merase in 1× PCR buffer [10 mM Tris-
HCl (pH 9.0 at 25°C), 50 mM KCl, and
0.1% Triton X-100]. After an initial denat-
uration at 94°C for 4 min, the DNA was
amplified by 30 cycles of 1 min at 94°C,
1 min at 60°C, and 1 min at 72°C, and
then by a final extension step of 5 min at
72°C. The PCR product was digested with
StyI for 8 hr at 37°C. The digestion prod-
ucts were then resolved on a 3% agarose gel
containing ethidium bromide. The homo-
zygous wild-type (Asp/Asp) was identified
by two DNA bands (507 and 244 bp), the
homozygous mutant type (Asn/Asn) pro-
duced three bands (474, 244, and 33 bp),
and heterozygotes (Asp/Asn) displayed all
four bands (507, 474, 244, and 33 bp).
The XPD Lys751Gln polymorphism, a
transversion A→C in exon 23 (position
35931), was determined using the primers
(forward) 5´-CTGCTCAGCCTGGAG-
CAGCTAGA ATCAGAGGACGCTG-3´
and (reverse) 5´-AAGACCTTCTAGCAC-
CACCG-3´. The PCR condition consisted
of initial denaturation step at 95°C for
2 min, followed by 40 cycles of 94°C for
15 sec, 67°C for 30 sec, 72°C for 45 sec,
and ﬁnal extension step at 72°C for 5 min.
The 161-bp PCR product was digested
with PstI (Promega); the Gln allele was cut
into 41- and 120-bp fragments (Lys allele
not digested).
The XRCC3 Thr241Met polymor-
phism was determined using the primers
(forward) 5´-GCCTGGTGGTCATC-
GACTC-3´ and (reverse) 5´-ACAGG-
GCTCTGGAAGGCACTGCTCAGCTC
ACGCACC-3´ (underlined base modifies
primer sequence introducing a cut site in
the presence of the Met allele). The PCR
condition consisted of initial denaturation
step at 95°C for 2 min, followed by 40
cycles of 94°C for 15 sec, 60°C for 30 sec,
72°C for 45 sec, and ﬁnal extension step at
72°C for 5 min. The 136-bp PCR product
was digested with NcoI (Promega); the
Met allele was cut into 39- and 97-bp
fragments (Thr allele not digested)
(Matullo et al. 2001). 
For XRCC3 genotyping,the XRCC3
Thr241Met polymorphism, a T→C transi-
tion in exon 7 (position 18067) was deter-
mined using the following primers: sense,
5´-GCCTGGTGGTCATCGACTC-3´;
antisense, 5´-ACAGGGCTCTGGAAG-
GCACTGCTCAGCTCACGCACC-3´.
The PCR conditions consisted of 100 ng
genomic DNA, 1.5 mM MgCl2, 200 µM
each dNTP, 0.5 U Taq, and 250 nM of
each primer in 1× PCR buffer. The PCR
program was as follows: a 3-min denatura-
tion step at 94°C, followed by 35 cycles of
95°C for 1 min, 60°C for 1 min, and 72°C
for 1 min, followed by ﬁnal extension step
at 72°C for 5 min. The 136-bp PCR prod-
uct was digested with NcoI restriction
enzyme at 37°C for 6 hr; the Met allele was
cut into 39- and 97-bp fragments (Thr
allele not digested) (Matullo et al. 2001).
For APE1 genotyping (Hu et al.
2001), the polymorphism in APE1, exon
5, T/G, 148 Asp/Glu, was determined
using the following primers: forward,
5´-CTGTTTCATTTCTATAGGCTA-3´;
reverse, 5´-AGGAACTTGCGAAAG-
GCTTC-3´. About 100 ng genomic DNA
in a total volume of 50 µL was ampliﬁed by
PCR. The reaction mixture consisted of
PCR buffer (150 mM Tris–HCl, pH 8.0,
500 mM KCl), 2.5 mM MgCl2, 0.2 mM
each dNTP, 0.2 µM each primer, and 1 U
Taq polymerase. PCR conditions were
95°C for 2 min, followed by 40 cycles of
94°C for 15 sec, 57°C for 45 sec, 72°C for
45 sec, and a ﬁnal elongation step at 72°C
for 5 min. The 64-bp PCR product was
digested with the BfaI restriction enzyme
at 37°C for 6 hr. The restricted products
of APE1 codon 148 Asp/Asp, Asp/Glu,
and Glu/Glu genotypes are represented
by band sizes of 164, 164/144/20, and
144/20 bp, respectively.
Statistical Analysis
The genotype and chromosome data were
collected by two individuals and entered
into a spreadsheet data ﬁle without further
modiﬁcation and used for statistical analy-
ses by a third individual. All statistical tests
were performed with the software SPSS for
Windows (version 10; SPSS Inc., Chicago,
IL). CA was expressed as mean ± standard
error of the mean (SE). Statistical signifi-
cance was determined using analysis of vari-
ance (ANOVA), followed by Bonferroni’s
correction for multiple comparisons when
the overall F-test was significant. CA
frequency was further compared using
stratiﬁed analysis by genotype after adjusting
for potential confounders in a general linear
model. An alpha error (p) of less than 0.05
was used as the criterion of significance.
Significant levels (p-values) correspond to
two-sided tests.
Results
Characteristics of the Study
Population
A total of 80 subjects participated in the
current study. The use of donated blood
specimens for the various assays was deter-
mined purely based on the availability of
blood from the donors. Whole-blood lym-
phocyte cultures from 61 donors were
used to investigate the effect of DNA
repair polymorphisms in X-ray–induced
CA. Isolated blood lymphocyte cultures
from 49 donors were used to investigate
DNA repair polymorphisms in UV-
induced CA. As indicated in Table 1, there
is no significant difference in age, gender,
and distribution of the different genotypes
between the entire study population and
the two subpopulations. The genotype
data were based on two independent and
concordant determinations of each geno-
type. The distribution of the genotypes is
not consistent with Hardy-Weinberg equi-
librium. This observation is probably due
to our limited sample size of a highly selec-
tive population. However, our investiga-
tion focuses on individual responses based
on genotype composition of each individ-
ual and is not based on distribution of
genotypes in the population. Therefore,
the Hardy-Weinberg equilibrium condi-
tion does not affect the signiﬁcance of our
investigation.
Effect of X Rays and DNA Repair
Gene Polymorphisms on
Chromosome Aberrations 
Irradiation of the whole-blood cultures
from 61 donors with X rays resulted in the
induction of different types of CA.
Chromatid-type aberrations such as breaks
and exchanges and chromosome-type aber-
rations such as deletions and dicentrics
were observed. The frequencies of these
aberrations together with aberrant cells
indicating the percentage of cells that con-
tained any types of CA are summarized in
Table 2. Because X rays preferentially
induced chromosome-type aberrations such
as deletions and dicentrics (Au et al. 2001),
these aberrations were more frequently
observed than chromatid-type breaks and
exchanges (Table 2). Consequently, the
aberrant cells category has high frequency
as well. As shown in the table, XPD 312
Asn and XPD 751Gln are associated with
Toxicogenomics | Polymorphic DNA repair gene function
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most categories, with a reduction in
dicentrics for the combined heterozygous
and homozygous variant XPD 312Asn and
XPD 751Gln. The reduction in dicentrics
corresponded to the 2-fold increase of
another type of translocation, chromatid
exchanges (Table 2). Conversely, the
XRCC1, XRCC3, and APE1 variant geno-
types are associated with increased aberra-
tions in most categories. Significant
increases were observed for XRCC1
194Try in chromatid exchanges, XRCC1
399Gln in aberrant cells and deletions,
and XRCC3 241Met in deletions. Besides
the mentioned significant differences,
some variations in CA frequencies across
the study population were observed, but
these are normal observations in popula-
tion studies. The variations are probably
influenced by the presence of other poly-
morphic genotypes. 
Effect of Ultraviolet Light and DNA
Repair Gene Polymorphisms on
Chromosome Aberrations
Irradiation of the isolated lymphocyte
cultures from 49 donors with UV light
resulted in the induction of CA that can be
classified as aberrant cells, chromatid
breaks, chromatid exchanges, and chromo-
some deletions (Table 3). Dicentrics, a
chromosome-type translocation, were
rarely observed; therefore, this type of
abnormality was not meaningful for further
evaluation. Chromatid-type aberrations
such as breaks and exchanges are preferen-
tially induced by UV light (Au et al. 2001);
therefore, their frequencies are high and
the aberrant cells category also has high fre-
quencies. As shown in the table, XPD
312Asn and XPD 751Gln are consistently
associated with increased CA in every eval-
uated category (Table 3). Specifically, the
variant genotypes are significantly associ-
ated with increases in the aberrant cells and
chromatid breaks categories. The variant
genotypes for XRCC1,  XRCC3, and
APE1 are associated with increased CA
in the most observed category (Table 3).
However, significant association was
observed only in the aberrant cells category
for the XRCC1 194Trp. As mentioned ear-
lier, normal variations in CA frequencies
were observed.
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Table 2. Effect of X-ray exposure and DNA repair gene polymorphisms on chromosome aberrations.
Chromosome aberration type (mean ± SE)a
Genotype (n) Aberrant cells Chromatid breaks Chromatid exchanges Deletions Dicentrics
XPD-312
Asp/Asp (34) 27.50 ± 1.20 1.88 ± 0.30 0.65 ± 0.22 16.94 ± 1.10 12.21 ± 0.93
Asp/Asn + Asn/Asn (27) 25.15 ± 1.40  1.56 ± 0.33  1.33 ± 0.68  16.85 ± 1.31  09.85 ± 0.74
XPD-751
Lys/Lys (30) 27.50 ± 1.27 1.93 ± 0.36 0.67 ± 0.22 17.17 ± 1.20 12.47 ± 1.01
Lys/Gln + Gln/Gln (31) 25.45 ± 1.29  1.55 ± 0.26  1.23 ± 0.60 16.65 ± 1.19  09.90 ± 0.69*
XRCC1-194
Arg/Arg (43) 26.21 ± 1.11 1.58 ± 0.26 0.51 ± 0.15 16.74 ± 1.03 11.70 ± 0.74
Arg/Trp + Trp/Trp (18) 27.06 ± 1.61  2.11 ± 0.41  2.00 ± 1.01* 17.28 ± 1.47  09.88 ± 1.17
XRCC1-399
Arg/Arg (24) 24.17 ± 1.33 1.58 ± 0.34 0.92 ± 0.27 14.79 ± 1.20 10.21 ± 1.01
Arg/Gln + Gln/Gln (37) 27.95 ± 1.17* 1.84 ± 0.29  0.97 ± 0.51 18.27 ± 1.10* 11.83 ± 0.80
XRCC3-241
Thr/Thr (20) 24.45 ± 1.67 2.00 ± 0.44 0.60 ± 0.26 14.20 ± 1.39 10.45 ± 0.95
Thr/Met + Met/Met (41) 27.44 ± 1.06  1.61 ± 0.25  1.12 ± 0.46 18.22 ± 0.99* 11.55 ± 0.82
APE1-148
Asp/Asp (31) 25.00 ± 1.16 1.61 ± 0.30 0.65 ± 0.23 15.81 ± 1.11 10.61 ± 0.85
Asp/Glu + Glu/Glu (30) 27.97 ± 1.37  1.87 ± 0.33  1.27 ± 0.61 18.03 ± 1.24 11.79 ± 0.94
aExpressed as aberrations per 100 cells; aberrant cells contain cells that have any types of aberrations. *p < 0.05, ANOVA.
Table 1. Selected characteristics of the study population.
Variable All subjects, n (%) X rays, n (%) UV, n (%)
All subjects 80 61 49
Age, years (mean ± SE) 34.90 ± 0.82 34.51 ± 0.89 34.96 ± 0.99
Gender
Female 15 (19) 14 (23) 12 (24)
Male 65 (81) 47 (77) 37 (76)
XPD-312
Asp/Asp  40 (50) 34 (56) 27 (55)
Asp/Asn 34 (43) 23 (38) 18 (37)
Asn/Asn 6 (7) 4 (6) 4 (8)
XPD-751
Lys/Lys 39 (49) 30 (49) 26 (53)
Lys/Gln 32 (40) 25 (41) 17 (35)
Gln/Gln 09 (11) 06 (10) 06 (12)
XRCC1-194
Arg/Arg 54 (68) 43 (71) 31 (63)
Arg/Trp 24 (30) 18 (29) 18 (37)
Trp/Trp 2 (2) 0 (0) 0 (0)
XRCC1-399
Arg/Arg 32 (40) 24 (39) 19 (39)
Arg/Gln 37 (46) 26 (43) 22 (45)
Gln/Gln 11 (14) 11 (18) 08 (16)
XRCC3-241
Thr/Thr 27 (34) 20 (33)  17 (35)
Thr/Met 48 (60) 37 (61) 29 (59)
Met/Met 5 (6) 4 (6) 3 (6)
APE1-148
Asp/Asp 42 (53) 31 (51) 25 (51)
Asp/Glu 37 (46) 29 (47) 23 (47)
Glu/Glu 1 (1) 1 (2) 1 (2)Speciﬁcity of Genotypes on
Chromosome Aberrations
By plotting the experimental data from
Tables 2 and 3 into graphic formats, we
were able to visualize better the genotype-
speciﬁc effects on CA. The graphic formats
also allowed us to hypothesize interactions
among the different genotypes. We found
that variant gene alleles for BER (XRCC1
194Trp, XRCC1 399Gln, XRCC3 241Met,
and APE1 148Glu) but not those for NER
(XPD 312Asn and XPD 751Gln) are con-
sistently associated with defective repair of
X-ray–induced DNA damage. The most
revealing case involves the expression of
increased chromosome deletions preferen-
tially induced by X rays (Figure 1). Based
on the figure, we hypothesized that the
XRCC and APE variant genotypes would
interact with each other but not with
XPD variant genotypes. The analyses of the
interactions support our hypothesis
(Table 4). More important, gene dosage
effects were documented. Additional inter-
actions of genotypes (in combinations of
threes) were not evaluated because the
sample size for each group was too small to
be meaningful.
As shown in Figure 2, the data indicate
that the variant genotypes for NER genes
(XPD 312Asn and XPD 751Gln) are con-
sistently associated with defective repair of
UV light–induced DNA damage, leading
to signiﬁcant increase of chromatid breaks,
the aberrations preferentially induced by
UV light. Conversely, the BER genes
(XRCC and APE) are not significantly or
consistently involved with the repair of
this type of damage. Interactive effects of
variant genotypes in the repair of UV
light–induced DNA damage were further
investigated. As shown in Table 4, the only
signiﬁcant interactions were observed with
the XPD variant genotypes and for chro-
matid breaks preferentially induced by UV
light only. Significant gene–dosage effects
were detected. Furthermore, there was no
significant interaction between the BER
and the NER genes.
Discussion
The results from ongoing investigations
into the relationship between poly-
morphisms in DNA repair genes and
susceptibility to environmental cancer
have not yet produced consistent results
(Benhamou and Sarasin 2002; Goode et
al. 2002; Mohrenweiser et al. 2003).
However, the inconsistency is most likely
due to the complexity of the biological
process and of molecular epidemiological
investigations. A complementary approach
to investigate the role of these polymor-
phic genes in human disease is to use bio-
markers to conduct functional studies.
Functional investigations using biomark-
ers still need to be interpreted carefully on
the basis of their experimental design. For
example, the use of nonsmoking healthy
volunteers would allow us a better chance
to elucidate the function of the gene alle-
les than the use of cigarette smokers or
lung cancer patients because the latter
conditions could interfere with gene func-
tions. Furthermore, different biomarkers
provide different quality of data for
understanding the biological mechanisms
leading to disease (Bonassi and Au 2002).
For example, induction of CA and gene
mutations involves the contribution of a
spectrum of repair processes, and the data
can be used to indicate increased risk for
cancer. On the other hand, the presence
of DNA adducts is used as a biomarker
of exposure, and the extent of DNA repair
in modifying the adduct levels is not
yet clear. 
In our study we observed that XPD
312Asn is associated with significant
increase in UV light–induced CA (aberrant
cells and cells with chromatid breaks,
shown in Table 3) but with no increase of
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Figure 1. Differential repair of X-ray–induced damage by polymorphic DNA repair genes as indicated by
the chromosome deletion frequencies. 
*Signiﬁcant difference between the variant and WT genotypes, p < 0.05.
Table 3. Effect of UV exposure and DNA repair gene polymorphisms on chromosome aberrations.
Chromosome aberration type (mean ± SE)a
Genotype (n) Aberrant cells Chromatid breaks Chromatid exchanges Chromosome breaks
XPD-312
Asp/Asp (27) 09.04 ± 0.68 11.41 ± 0.98 0.44 ± 0.19 0.07 ± 0.07
Asp/Asn + Asn/Asn (22) 12.82 ± 1.02* 16.09 ± 1.36* 1.00 ± 0.37  0.27 ± 0.15
XPD-751
Lys/Lys (26) 08.46 ± 0.56 10.54 ± 0.87 0.38 ± 0.19 0.15 ± 0.11
Lys/Gln + Gln/Gln (23) 13.30 ± 0.99* 16.87 ± 1.27* 1.04 ± 0.35 0.17 ± 0.12
XRCC1-194
Arg/Arg (31) 09.60 ± 0.76 12.80 ± 1.18 0.53 ± 0.21 0.13 ± 0.08
Arg/Trp + Trp/Trp (18) 12.53 ± 1.05* 14.63 ± 1.26 0.95 ± 0.39 0.63 ± 0.14
XRCC1-399
Arg/Arg (19) 10.63 ± 1.05 12.84 ± 1.40 0.53 ± 0.34 0.30 ± 0.16
Arg/Gln + Gln/Gln (30) 10.80 ± 0.83 13.93 ± 1.13 0.80 ± 0.25 0.07 ± 0.07
XRCC3-241
Thr/Thr (17) 11.06 ± 1.06 13.65 ± 1.67 0.94 ± 0.39 0.35 ± 0.19
Thr/Met + Met/Met (32) 10.56 ± 0.82 13.44 ± 1.02 0.56 ± 0.22 0.06 ± 0.06
APE1-148
Asp/Asp (25) 10.40 ± 0.89 13.52 ± 1.26 0.64 ± 0.28 0.15 ± 0.11
Asp/Glu + Glu/Glu (24) 11.08 ± 0.95 13.50 ± 1.24 0.75 ± 0.29 0.17 ± 0.12
aExpressed as aberrations per 100 cells; aberrant cells contain cells that have any types of aberrations. *p < 0.05,
ANOVA.CA from X-ray–irradiated cultures. This
indicates specific defects in NER. The
chromosome data are consistent with the
involvement of the same genotype with a
nonsigniﬁcant increase of transversion p53
gene mutation in lung cancer patients
(Hou et al. 2003) but not with DNA
adducts levels in lymphocytes of lung
cancer patients (Pastorelli et al. 2002).
Similarly, our observation of speciﬁc DNA
repair defects in XPD 751Gln is consistent
with the significant increase of DNA
adducts among healthy nonsmokers
(Matullo et al. 2001) and with increased
transversion p53 mutation in lung cancer
patients (Hou et al. 2003) but not with
changes in DNA adducts in lymphocytes of
lung cancer patients (Pastorelli et al. 2002).
Our data also showed that XPD 312 Asn
and XPD 751Gln are associated with
slightly reduced aberration frequencies in
X-ray–challenged cells, with more reduc-
tion in dicentrics for the combined hetero-
zygous and homozygous variant XPD
312Asn and XPD 751Gln (Table 2).
However, this unexpected reduction in
dicentrics may be caused by the corre-
sponding 2-fold increase of another type of
translocation, chromatid exchanges.
With respect to XRCC1 194Trp, we
observed an association with increased
CA, but the increase is not consistent or
indicative of specific DNA repair defect.
This is similar to the lack of association
with p53 gene mutation in oral cancer
(Hsieh et al. 2003) and the lack of
increased DNA adducts (Pastorelli et al.
2002). Nevertheless, the defective DNA
repair activities interacted with XRCC1
399Gln to cause significant increase in
X-ray–induced chromosome deletions
(Table 4).
XRCC1 399Gln is associated with
significant and specific CA indicative of
defects in BER. This observation is consis-
tent with the report that XRCC1 399Gln
is associated with significant increase of
p53 gene mutation in oral cancer patients
(Hsieh et al. 2003), significant increase of
glycophorin A mutations in normal smok-
ers and nonsmokers (Lunn et al. 1999),
and signiﬁcant increase of DNA adducts in
normal nonsmokers (Matullo et al. 2001).
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Table 4. Effect of exposure and combined DNA repair gene polymorphisms on chromosome aberrations.
Genotypes X Rays  UV
XPD-312 XPD-751 XRCC1-194 XRCC1-399 XRCC3-241 APE1-148 Meana ± SE (n) Meana ± SE (n)
Chromatid breaks
WW WW 09.96 ± 1.18 (20)
WM or MM WW 13.79 ± 2.16 (6)0
WW WM or MM 15.57 ± 2.03 (7)0
WM or MM WM or MM 16.93 ± 1.32 (16)*
p = 0.002b
Deletions
WW WW 12.33 ± 1.72 (14)
WM or MM WW 18.14 ± 1.99 (10)
WW WM or MM 18.85 ± 1.17 (29)*
WM or MM WM or MM 16.28 ± 2.24 (8)
p = 0.021b
Deletions
WW WW 12.42 ± 2.04 (10)
WM or MM WW 16.00 ± 2.02 (10)
WW WM or MM 16.50 ± 1.70 (14)
WM or MM WM or MM 19.10 ± 1.22 (27)*
p = 0.041b
Deletions
WW WW 13.91 ± 2.03 (10)
WM or MM WW 16.65 ± 1.41 (21)
WW WM or MM 14.60 ± 2.02 (10)
WM or MM WM or MM 19.81 ± 1.43 (20)
p = 0.066b
Abbreviations: MM, mutant homozygous; WM, wild-type/mutant heterozygous; WW, wild-type homozygous.
aMean values are adjusted by age and gender in the general linear model. bp-Value based on ANOVA test. *p < 0.05 compared with WW + WW genotype, based on post-ANOVA testing
with Bonferroni’s correction for multiple comparisons. Interactions among the other combinations of genotypes were either not signiﬁcant (see also Figures 1 and 2) or not meaningful
because the sample sizes were too small.
*
*
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Figure 2. Differential repair of UV light–induced damage by polymorphic DNA repair genes as indicated by
the chromatid break frequencies.
*Signiﬁcant difference between the variant and WT genotypes, p < 0.05.However, our data are not consistent with
the lack of increase of p53 gene mutations
in lung cancer patients (Hou et al. 2003)
and the lack of increased DNA adducts in
lung cancer patients (Pastorelli et al. 2002).
We showed that XRCC3 241Met is
associated with BER defects. However, our
data are not consistent with the lack of
increase of DNA adducts in healthy donors
(Matullo et al. 2001).
APE1 148Gln is associated with some
repair defects and significant interactions
with XRCC3 241Met. However, we have
not been able to ﬁnd any biomarker data in
the literature to support or refute our
observations.
On the basis of our data, we have
observed a significant genotype-specific
repair defects to the inducing agents,
especially XRCC1 399Gln and XRCC3
241Met for X-rays, and XPD 312Asn and
XPD 751Gln for UV light. More impor-
tant, heterozygous and homozygous vari-
ant genotypes are consistently associated
with higher CA than the wild-type genes.
Combinations of variant genotypes also
showed an increase in CA compared with
the corresponding combined wild-type
genes. Our precise observation is sup-
ported by a variety of studies in the litera-
ture although there are discrepancies.
Most of the discrepancies are due to
incompatible comparison with different
studies; for example, the use of cigarette
smokers, cancer patients, and inappropri-
ate biomarkers in the other investigations.
We believe that we are able to show the
relatively precise response because our
experimental conditions are vigorously
controlled and the conditions are favor-
able for the elucidation of the function of
the variant genotypes. For example; the
use of X rays and UV light to elucidate
DNA repair activities is not affected by
many confounding factors that can influ-
ence similar investigations using chemi-
cals; for example, individual differences
in cellular uptake, metabolism, and distri-
bution of chemicals. The existence of
polymorphic chemical-metabolizing genes
in the population can further complicate
the interpretation of results from studies
using chemicals. In addition, the use of
different types of CA indicative of repair
defects from X rays and UV light allows
us to elucidate the efficiency in DNA
repair more precisely compared with
other biomarkers.
Our data also indicate that the
functions of the variant genotypes are com-
plementary to each other in the same repair
pathway, with limited overlap of genes
from the other pathways. This suggests that
individuals who have different variant
genotypes that act in the same repair path-
way may have further elevated risk for envi-
ronmental disease due to synergistic
interactions among the genotypes.
Using carefully selected DNA damage–
inducing agents and appropriate biomark-
ers, we have provided data to indicate that
some of the variant genotypes are associ-
ated with specific DNA repair defects.
Specifically, XRCC1 399Gln and XRCC3
241Met in BER and XPD 312Asn and
XPD 751Gln for NER are significantly
defective. In addition, these genotypes
interact signiﬁcantly with each other with-
out significant overlap of different repair
pathways. No genotypes, either singly or in
combination, are associated with enhanced
repair activities that lead to significantly
increased CA under our experimental
conditions. The information is helpful in
understanding the functions of polymor-
phic DNA repair genes and their role for
susceptibility to environmental cancer.
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